A new study has out together a first ever randomized clinical trial evaluating a whole new genome sequence in healthy people. The evaluators had come to the conclusion of that the sequencing of genomes in healthy adults there is a chance of one in five people being risk marker for rare diseases or genetic mutations associated with cancers. The article goes to say how the it is beneficial because it is an advantage to study the implementation rather making assumptions without evidence. In the case study there was an observation of 100 healthy adults who reported their family to their primary care physician initially and half were randomly assigned to undergo an additional full genomic workup. From here it was shown that there was 5 million subtle DNA sequence changes from as single nucleotide variants across 4600 genes, which from there resulted for jus t 59 genes to strongly expect to cause a disease. It was the 50 participants who genome that were sequenced 11 had at least one letter of DNA to a have a rare disease. Like one of the patients would was extremely sensitive to the sun. It was also sad the sequenced patients carried at least one recessive mutation linked to a disease. It goes to say how it could be beneficial for the healthcare system to use this technology but it a bit early to useful in the clinics. After reading this article I found it very interesting because after I was diagnosed with hypothyroidism and my doctor told me it is predisposed because my mom had hypothyroidism I did more research and read that this a increased of risk of a family member inheriting it too. I find it interesting and beneficial because in the future it is beneficial for reproductive decisions.
